OC 02.5 Mim8 (denecimig) prophylaxis in children with haemophilia A with or without inhibitors: Interim safety and efficacy results from the FRONTIER4 long-term extension study

IF 3.5 3区医学 Q2 HEMATOLOGY

Research and Practice in Thrombosis and Haemostasis Pub Date : 2026-09-01 Epub Date: 2026-10-05 DOI:10.1016/j.rpth.2026.103473

Manuel Carcao, Meera Chitlur, Karin Fijnvandraat, Ida Frandsen, Gili Kenet, Runhui Wu, Jay Jay Thaung Zaw, Carmen Escuriola Ettingshausen

引用次数: 0

查看原文本刊更多论文

有或没有抑制剂的A型血友病儿童的oc02.5 Mim8（去乙酰化）预防：来自FRONTIER4长期扩展研究的中期安全性和有效性结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Research and Practice in Thrombosis and Haemostasis Medicine-Hematology

CiteScore

5.60

自引率

13.00%

发文量

212

审稿时长

7 weeks